PRMA Insights is a unique series of strategic publications addressing the critical global pricing, reimbursement and market access challenges and opportunities by disease area. Each comprehensive resource critically reviews all the major health technology assessment (HTA) and pricing and reimbursement decisions by disease area in the US, UK, France, Germany, Spain, Italy and Japan, and unravels the complexity around pricing and reimbursement. It delivers actionable insights to apply to your clinical development program in order to develop a robust evidence-based payer-value proposition.
Written by a team of industry-experienced individuals, each resource provides comprehensive secondary research, experience-based insight, and validation by payers and key opinion leaders (KOLs) across markets. PRMA Insights helps to minimise the market access risk and to maximize the market opportunity for commercial success.Each disease-specific resource will enable you to: